[1]
|
Simancas-Racines, D., Arevalo-Rodriguez, I., Osorio, D., Franco, J.V., Xu, Y. and Hidalgo, R. (2018) Interventions for Treating Acute High Altitude Illness. Cochrane Database of Systematic Reviews, 6, Article ID: CD009567.
https://doi.org/10.1002/14651858.CD009567.pub2
|
[2]
|
Lee, E., Yim, S., Lee, S.K. and Park, H. (2002) Two Transactivation Domains of Hypoxia-Inducible Factor-1alpha Regulated by the MEK-1/p42/p44 MAPK Pathway. Mole-cules and Cells, 14, 9-15.
|
[3]
|
Dzhalilova, D. and Makarova, O. (2020) Differences in Tolerance to Hypoxia: Physio-logical, Biochemical, and Molecular-Biological Characteristics. Biomedicines, 8, Article No. 428. https://doi.org/10.3390/biomedicines8100428
|
[4]
|
Richalet, J.P., Larmignat, P., Poitrine, E., Letournel, M. and Canouï-Poitrine, F. (2012) Physiological Risk Factors for Severe High-Altitude Illness: A Prospective Cohort Study. American Journal of Respiratory and Critical Care Medicine, 185, 192-198. https://doi.org/10.1164/rccm.201108-1396OC
|
[5]
|
Schneider, M., Bernasch, D., Weymann, J., et al. (2002) Acute Mountain Sickness: Influence of Susceptibility, Preexposure, and Ascent Rate. Medicine and Science in Sports and Exer-cise, 34, 1886-1891.
https://doi.org/10.1097/00005768-200212000-00005
|
[6]
|
Webb, J.D., Coleman, M.L. and Pugh, C.W. (2009) Hypoxia, Hypoxia-Inducible Factors (HIF), HIF Hydroxylases and Oxygen Sensing. Cellular and Molecular Life Sci-ences, 66, 3539-3554. https://doi.org/10.1007/s00018-009-0147-7
|
[7]
|
Minamino, T., Christou, H., Hsieh, C.M., Liu, Y., Dhawan, V., Abraham, N.G., Perrella, M.A., Mitsialis, S.A. and Kourembanas, S. (2001) Targeted Expression of Heme Oxygenase-1 Prevents the Pulmonary Inflammatory and Vascular Responses to Hypoxia. Proceedings of the National Academy of Sciences of the United States of America, 98, 8798-803. https://doi.org/10.1073/pnas.161272598
|
[8]
|
Agita, A. and Alsagaff, M.T. (2017) Inflammation, Immunity, and Hypertension. Acta Medica Indonesiana, 49, 158-165.
|
[9]
|
Maron, B.A., Kovacs, G., Vaidya, A., Bhatt, D.L., Nishi-mura, R.A., Mak, S., Guazzi, M. and Tedford, R.J. (2020) Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week. Journal of the American College of Cardiology, 76, 2671-2681. https://doi.org/10.1016/j.jacc.2020.10.007
|
[10]
|
Villafuerte, F.C., Macarlupú, J.L., Anza-Ramírez, C., Cor-rales-Melgar, D., Vizcardo-Galindo, G., Corante, N. and León-Velarde, F. (2014) Decreased Plasma Soluble Erythropoi-etin Receptor in High-Altitude Excessive Erythrocytosis and Chronic Mountain Sickness. Journal of Applied Physiology, 117, 1356-1362.
https://doi.org/10.1152/japplphysiol.00619.2014
|
[11]
|
West, J.B. (2011) Con: Headache Should Not Be a Required Symptom for the Diagnosis of Acute Mountain Sickness. High Altitude Medicine & Biology, 12, 23-25. https://doi.org/10.1089/ham.2010.1068
|
[12]
|
Marshall, J.M. (2015) Interactions between Local Dilator and Sympa-thetic Vasoconstrictor Influences in Skeletal Muscle In acute and Chronic Hypoxia. Experimental Physiology, 100, 1400-1411. https://doi.org/10.1113/EP085139
|
[13]
|
Bärtsch, P. and Bailey, D.M. (2014) Acute Mountain Sickness and High Altitude Cerebral Oedema. In: Swenson, E. and Bärtsch, P., Eds., High Altitude, Springer, New York, 379-404.
https://doi.org/10.1007/978-1-4614-8772-2_20
|
[14]
|
Davis, C. and Hackett, P. (2017) Advances in the Prevention and Treatment of High Altitude Illness. Emergency Medicine Clinics, 35, 241-260. https://doi.org/10.1016/j.emc.2017.01.002
|
[15]
|
Sampson, J.B., Cymerman, A., Burse, R.L., Maher, J.T. and Rock, P.B. (1983) Procedures for the Measurement of Acute Mountain Sickness. Aviation, Space, and Environmental Medicine, 54, 1063-1073.
|
[16]
|
Wilson, M.H., Newman, S. and Imray, C.H. (2009) The Cerebral Effects of Ascent to High Alti-tudes. The Lancet Neurology, 8, 175-191. https://doi.org/10.1016/S1474-4422(09)70014-6
|
[17]
|
Smedley, T. and Grocott, M.P. (2013) Acute High-Altitude Illness: A Clinically Orientated Review. British Journal of Pain, 7, 85-94. https://doi.org/10.1177/2049463713489539
|
[18]
|
Hall, D.P., Duncan, K. and Baillie, J.K. (2011) High Altitude Pulmonary Oedema. BMJ Military Health, 157, 68-72.
https://doi.org/10.1136/jramc-157-01-12
|
[19]
|
Maggiorini, M. (2010) Prevention and Treatment of High-Altitude Pulmonary Edema. Progress in Cardiovascular Diseases, 52, 500-506. https://doi.org/10.1016/j.pcad.2010.03.001
|
[20]
|
Scherrer, U., Rexhaj, E., Jayet, P.Y., Allemann, Y. and Sartori, C. (2010) New Insights in the Pathogenesis of High-Altitude Pulmonary Edema. Progress in Cardiovascular Diseases, 52, 485-492.
https://doi.org/10.1016/j.pcad.2010.02.004
|
[21]
|
Imray, C., Wright, A., Subudhi, A. and Roach, R. (2010) Acute Mountain Sickness: Pathophysiology, Prevention, and Treatment. Progress in Cardiovascular Diseases, 52, 467-484. https://doi.org/10.1016/j.pcad.2010.02.003
|
[22]
|
Wu, T., Ding, S., Liu, J., et al. (2006) Ataxia: An Early Indicator in High Altitude Cerebral Edema. High Altitude Medicine & Biology, 7, 275-280. https://doi.org/10.1089/ham.2006.7.275
|
[23]
|
Consolazio, C.F., Matoush, L.O., Johnson, H.L., et al. (1969) Effects of a High-Carbohydrate Diet on Performance and Clinical Symptomology after Rapid Ascent to High Altitude. Federa-tion Proceedings, 28, 937-943.
|
[24]
|
Golja, P., Flander, P., Klemenc, M., Maver, J. and Princi, T. (2008) Carbohydrate Ingestion Improves Oxygen Delivery in Acute Hypoxia. High Altitude Medicine & Biology, 9, 53-62. https://doi.org/10.1089/ham.2008.1021
|
[25]
|
Lawless, N.P., Dillard, T.A., Torrington, K.G., Davis, H.Q. and Ka-mimori, G. (1999) Improvement in Hypoxemia at 4600 Meters of Simulated Altitude with Carbohydrate Ingestion. Avia-tion, Space, and Environmental Medicine, 70, 874-878.
|
[26]
|
Hackett, P.H. and Roach, R.C. (2001) High-Altitude Illness. New England Journal of Medicine, 345, 107-114.
https://doi.org/10.1056/NEJM200107123450206
|
[27]
|
Pollard, A.J. (1992) Altitude Induced Illness. British Medi-cal Journal, 304, 1324-1325.
https://doi.org/10.1136/bmj.304.6838.1324
|
[28]
|
Ellsworth, A.J., Larson, E.B. and Strickland, D. (1987) A Ran-domized Trial of Dexamethasone and Acetazolamide for Acute Mountain Sickness Prophylaxis. The American Journal of Medicine, 83, 1024-1030.
https://doi.org/10.1016/0002-9343(87)90937-5
|
[29]
|
Committee to Advise on Tropical Medicine and Travel (CATMAT) (2007) Statement on High-Altitude Illnesses. An Advisory Committee Statement (ACS). Canada Com-municable Disease Report, 33, 1-20.
|
[30]
|
Nerín, M.A., Palop, J., Montaño, J.A., Morandeira, J.R. and Vázquez, M. (2006) Acute Mountain Sickness: Influence of Fluid Intake. Wilderness & Environmental Medicine, 17, 215-220.
https://doi.org/10.1580/1080-6032(2006)17[215:AMSIOF]2.0.CO;2
|
[31]
|
Richardson, A., Watt, P. and Maxwell, N. (2009) Hydration and the Physiological Responses to Acute Normobaric Hypoxia. Wilderness & Environmental Medicine, 20, 212-220. https://doi.org/10.1580/09-WEME-OR-272R1.1
|
[32]
|
van Patot, M.C., Leadbetter 3rd., G., Keyes, L.E., et al. (2008) Prophylactic Low-Dose Acetazolamide Reduces the Incidence and Severity of Acute Mountain Sickness. High Altitude Medicine & Biology, 9, 289-293.
https://doi.org/10.1089/ham.2008.1029
|
[33]
|
Basnyat, B., Gertsch, J.H., Johnson, E.W., et al. (2003) Efficacy of Low-Dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-Blind, Randomized, Placebo-Controlled Trial. High Altitude Medicine & Biology, 4, 45-52. https://doi.org/10.1089/152702903321488979
|
[34]
|
Dumont, L., Mardirosoff, C. and Tramer, M. (2003) Efficacy and Harm of Pharmacological Prevention of Acute Mountain Sickness: Quantitative Systematic Review. British Medical Journal, 321, 267-272.
https://doi.org/10.1136/bmj.321.7256.267
|
[35]
|
Basnyat, B., Gertsch, J.H., Holck, P.S., et al. (2006) Acetazolamide 125 mg BD Is Not Significantly Different from 375 mg BD in the Prevention of Acute Mountain Sickness: The Prophy-lactic Acetazolamide Dosage Comparison for Efficacy (PACE) Trial. High Altitude Medicine & Biology, 7, 17-27. https://doi.org/10.1089/ham.2006.7.17
|
[36]
|
Carlsten, C., Swenson, E.R. and Ruoss, S. (2004) A Dose-Response Study of Acetazolamide for Acute Mountain Sickness Prophylaxis in Vacationing Tourists at 12,000 Feet (3630 m). High Altitude Medicine & Biology, 5, 33-39.
https://doi.org/10.1089/152702904322963672
|
[37]
|
Greene, M.K., Kerr, A.M., McIntosh, I.B. and Prescott, R.J. (1981) Acetazolamide in Prevention of Acute Mountain Sickness: A Double-Blind Controlled Cross-Over Study. British Medical Journal, 283, 811-813.
https://doi.org/10.1136/bmj.283.6295.811
|
[38]
|
Her, Y., Kil, M.S., Park, J.H., Kim, C.W. and Kim, S.S. (2011) Stevens-Johnson Syndrome Induced by Acetazol-Amide. The Journal of Dermatology, 38, 272-275. https://doi.org/10.1111/j.1346-8138.2010.00921.x
|
[39]
|
Collier, D.J., Wolff, C.B., Hedges, A.-M., et al. (2016) Benzolamide Improves Oxygenation and Reduces Acute Mountain Sickness during a High-Altitude Trek and Has Fewer Side Effects than Acetazolamide at Sea Level. Pharmacology Research & Perspectives, 4, e00203. https://doi.org/10.1002/prp2.203
|
[40]
|
Ellsworth, A.J., Meyer, E.F. and Larson, E.B. (1991) Acetazolamide or Dexamethasone Use versus Placebo to Prevent Acute Mountain Sickness on Mount Rainier. Western Journal of Medi-cine, 154, 289-293.
|
[41]
|
Chen, G.-Z., Zheng, C.-R., Qin, J., et al. (2015) Inhaled Budesonide Prevents Acute Mountain Sickness in Young Chinese Men. Journal of Emergency Medicine, 48, 197-206. https://doi.org/10.1016/j.jemermed.2014.07.047
|
[42]
|
Zheng, C.-R., Chen, G.-Z., Yu, J., et al. (2014) Inhaled Budesonide and Oral Dexamethasone Prevent Acute Mountain Sickness. The American Journal of Medicine, 127, 1001-1009. https://doi.org/10.1016/j.amjmed.2014.04.012
|
[43]
|
Luks, A.M., McIntosh, S.E., Grissom, C.K., Au-erbach, P.S., Rodway, G.W., Schoene, R.B., et al. (2010) Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness. Wilderness & Environmental Medicine, 21, 146-155. https://doi.org/10.1016/j.wem.2010.03.002
|
[44]
|
Bartsch, P., Maggiorini, M., Ritter, M., Noti, C., Vock, P. and Oelz, O. (1991) Prevention of High-Altitude Pulmonary Edema by Nifedipine. New England Journal of Medicine, 325, 1284-1289.
https://doi.org/10.1056/NEJM199110313251805
|
[45]
|
Sartori, C., Allemann, Y., Duplain, H., Lepori, M., Egli, M., Lipp, E., et al. (2002) Salmeterol for the Prevention of High-Altitude Pulmonary Edema. New England Journal of Medi-cine, 346, 1631-1636.
https://doi.org/10.1056/NEJMoa013183
|
[46]
|
Maggiorini, M., Brunner-La Rocca, H.P., Peth, S., Fischler, M., Bohm, T., Bernheim, A., et al. (2006) Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema: A Randomized Trial. Annals of Internal Medicine, 145, 497-506. https://doi.org/10.7326/0003-4819-145-7-200610030-00007
|
[47]
|
Luks, A.M., Auerbach, P.S., Freer, L., Grissom, C.K., Keyes, L.E., McIntosh, S.E., Rodway, G.W., Schoene, R.B., Zafren, K. and Hackett, P.H. (2019) Wilderness Medical Society Clinical Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update. Wilderness & Environmental Medicine, 30, S3-S18.
https://doi.org/10.1016/j.wem.2019.04.006
|
[48]
|
Gertsch, J.H., Corbett, B., Holck, P.S., Mulcahy, A., Watts, M., Stillwagon, N.T., et al. (2012) Altitude Sickness in Climbers and Efficacy of NSAIDs Trial (ASCENT): Randomized, Controlled Trial of Ibuprofen versus Placebo for Prevention of Altitude Illness. Wilderness & Environmental Medicine, 23, 307-315.
https://doi.org/10.1016/j.wem.2012.08.001
|
[49]
|
Lipman, G.S., Kanaan, N.C., Holck, P.S., Constance, B.B. and Gertsch, J.H. (2012) Ibuprofen Prevents Altitude Illness: A Randomized Controlled Trial for Prevention of Altitude Ill-ness with Nonsteroidal Anti-Inflammatories. Annals of Emergency Medicine, 59, 484-490. https://doi.org/10.1016/j.annemergmed.2012.01.019
|
[50]
|
Lundeberg, J., Feiner, J.R., Schober, A., Sall, J.W., Eilers, H. and Bickler, P.E. (2018) Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sick-ness, Physiological Variables, or Cytokine Levels. High Altitude Medicine & Biology, 19, 249-258. https://doi.org/10.1089/ham.2017.0144
|